Theranos Is Getting Rid of High-Profile Board Members Including Henry Kissinger and George Shultz

In 2017, the company said, the board of counselors will be retired.

By Lydia Ramsey

Larry Busacca/Getty via Business Insider
Elizabeth Holmes

This story originally appeared on Business Insider

Theranos is making a huge change to its leadership.

In 2017, the company said, the board of counselors will be retired. The board of counselors consisted mostly of former directors with strong government connections but little scientific experience, such as Henry Kissinger and George Shultz, and it served as an advisory board to the company's founder, Elizabeth Holmes.

James Mattis, a retired Marine general who is President-elect Donald Trump's pick for secretary of defense, will stay on the company's board of directors.

Theranos also announced that Riley Bechtel, who sat on the board of directors, would also be departing immediately, citing health issues. On Monday, The Wall Street Journal reported that Bechtel had invested in Theranos, which hadn't been publicly disclosed.

When the blood-testing company was first facing major criticism over its technology in October 2015, one of the problems cited was that its board of directors included few professionals with science credentials. To counter that, Theranos moved many of those members onto a board of counselors and later made a scientific and medical advisory board.

The members of the board of counselors are among some of the highest-profile names supporting Theranos and Holmes, who is the company's CEO.

Among those who will no longer be with the company:

  • Henry A. Kissinger -- former U.S. secretary of state
  • William H. Frist -- heart and lung transplant surgeon and former U.S. senator
  • Sam Nunn -- former U.S. senator who served as chairman of the Senate Armed Services Committee and the Permanent Subcommittee on Investigations
  • William J. Perry -- former U.S. secretary of defense
  • George P. Shultz -- former U.S. secretary of state
  • Gary Roughead -- retired U.S. Navy admiral

Here's Theranos' current board of directors, including Daniel Warmenhoven, who will be replacing Bechtel.

  • Elizabeth Holmes -- CEO and chairman of the board of Theranos
  • James N. Mattis -- retired U.S. Marine Corps general and President-elect Donald Trump's pick for secretary of defense
  • David Boies -- lawyer and chairman of Boies, Schiller & Flexner LLP, who until November, The Journal reports, Theranos had used for legal work as well
  • Daniel Warmenhoven -- former CEO at NetApp
  • William H. Foege -- former director of the Centers for Disease Control and Prevention
  • Richard Kovacevich -- former CEO of Wells Fargo
  • Fabrizio Bonanni -- former executive vice president at the biopharmaceutical company Amgen
Lydia Ramsey

Reporter

Lydia is a reporter for Business Insider, covering the pharmaceutical and biotech industries.

Related Topics

Editor's Pick

Everyone Wants to Get Close to Their Favorite Artist. Here's the Technology Making It a Reality — But Better.
The Highest-Paid, Highest-Profile People in Every Field Know This Communication Strategy
After Early Rejection From Publishers, This Author Self-Published Her Book and Sold More Than 500,000 Copies. Here's How She Did It.
Having Trouble Speaking Up in Meetings? Try This Strategy.
He Names Brands for Amazon, Meta and Forever 21, and Says This Is the Big Blank Space in the Naming Game
Green Entrepreneur

A Massive Hole In the Sun May Cause Dazzling Light Show Here On Earth

NASA says the coronal hole could blast the Earth with solar winds as early as Friday. What does this mean?

Business News

'Wanted by Several Countries.' Crypto Fugitive Is Nabbed in Montenegro.

Do Kwon was wanted in South Korea and the U.S. on fraud charges related to TerraUSD and Luna crash.

Business News

Gen Z Loves the Toyota Camry. Here's What Car Brands Boomers Love Most

S&P Global Mobility provides data on what types of each age group likes the most, based on car registration.

Leadership

Why Failure is a Choice You Make

Failure is a product of our mind and therefore we determine if it exists or not. Learn more empowering ways to view situations where failure becomes a stepping stone, not a roadblock.

Fundraising

Working Remote? These Are the Biggest Dos and Don'ts of Video Conferencing

As more and more businesses go remote, these are ways to be more effective and efficient on conference calls.